CONTACT US   |  (864) 397-5101

MUSC Named to 60 health systems with great oncology programs headed into 2023 by Becker’s

musc health

Becker’s Hospital Review is pleased to release its top oncology hospitals. The hospitals and health systems featured on this list have earned recognition nationally as top cancer care providers and many are on the cutting edge of novel therapies and researcher to improve outcomes and access to care.

The hospitals and health systems below are among the vanguard of cancer treatment and research in the country. Many of them have earned National Cancer Institute comprehensive cancer center designation and are ranked among the top hospitals for cancer care by U.S. News & World Report.

The list also features cancer centers with busy research institutes, multiple clinical trials and safety designations that exceed national benchmarks. Hospitals and health systems listed below are dedicated to expanding their oncology departments and regional cancer centers to improve patient care locally and nationally. We accepted nominations for this list. Click here to find the 2023 nomination forms.

MUSC Hollings Cancer Center (Charleston, S.C.). MUSC Hollings Cancer Center is the only NCI-designated cancer center in South Carolina. Specialists from more than 20 academic departments work together to study and treat cancer through three programs: the cancer biology and immunology, cancer control and therapeutics development. Clinicians and researchers also focus on cutting-edge research; the center supports more than 200 clinical trials and has an annual research funding portfolio of more than $44 million.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.